statements

Denis Chem Lab Ltd.

BSE: 537536

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

73.00+0.5 (+0.69%)

26 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Denis Chem Lab Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	41.57	56.03	99.64	113.36	107.22	124.12	136.15	109.32	136.56	160.85	167.82	173.30	181.72	182.44
Cost of Operating Revenue	30.07	38.45	68.46	60.70	55.40	68.09	68.23	61.39	78.10	92.27	93.81	112.59	114.71	105.76
Gross Profit	11.50	17.57	31.19	52.66	51.82	56.03	67.92	47.92	58.45	68.57	74.02	60.71	67.01	76.68
Gross Margin	27.7	31.4	31.3	46.5	48.3	45.1	49.9	43.8	42.8	42.6	44.1	35.0	36.9	42.0
Total Operating Expenses	38.70	51.50	96.80	106.24	101.10	116.62	127.81	105.02	127.96	149.88	153.53	164.05	170.91	172.53
Operating Profit	2.87	4.53	2.84	7.12	6.12	7.50	8.34	4.29	8.59	10.96	14.29	9.25	10.81	9.91
Operating Margin	6.9	8.1	2.9	6.3	5.7	6.0	6.1	3.9	6.3	6.8	8.5	5.3	6.0	5.4
Financing Income/(Expense) - Net	-1.87	-2.13	-6.73	-5.80	-4.61	-3.25	-2.89	-1.55	-0.76	-0.64	-0.54	1.34	1.05	-0.76
Profit before Taxes	1.23	2.54	-3.42	1.97	2.04	5.92	5.73	3.09	8.88	10.92	15.13	11.11	11.90	11.22
Income Taxes	0.44	0.86	1.03	0.73	-0.10	-0.43	1.51	0.82	2.62	3.06	3.98	3.04	3.49	3.24
Profit after Tax	0.79	1.68	-4.45	1.24	2.14	6.35	4.21	2.26	6.26	7.86	11.16	8.08	8.41	7.98
PAT Margin	1.9	3.0	-4.5	1.1	2.0	5.1	3.1	2.1	4.6	4.9	6.6	4.7	4.6	4.4
EPS - Basic - ex Extraordinary Items	5.23	10.58	-4.66	1.00	1.69	4.58	3.04	1.63	4.51	5.66	8.04	5.82	6.06	5.75
EPS - Diluted - ex Extraordinary Items	5.23	10.58	-4.66	1.00	1.69	4.58	3.04	1.63	4.51	5.66	8.04	5.82	6.06	5.75
EBIT	2.87	4.53	2.84	7.12	6.12	7.50	8.34	4.29	8.59	10.96	14.29	9.25	10.81	9.91
EBITDA	4.24	5.82	8.48	13.89	12.05	13.85	15.00	10.25	14.35	18.78	21.23	16.11	17.65	16.67
EBITDA Margin	10.2	10.4	8.5	12.3	11.2	11.2	11.0	9.4	10.5	11.7	12.7	9.3	9.7	9.1

Balance Sheet

Abridged

Understanding Balance Sheet

Denis Chem Lab Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	16.00	23.99	33.89	47.81	52.76	54.16	50.04	48.55	53.46	59.24	69.37	70.64	85.34
Long-Term Investments	0.21	0.30	0.06	0.06	0.06	0.79	1.20	1.59	0.98	1.52	1.27	2.16	2.09
Property Plant & Equipment - Net	-	0.04	49.38	44.80	44.65	50.27	45.68	41.33	41.33	37.32	37.67	38.79	37.01
Total Non-Current Assets	10.04	10.70	50.87	46.29	48.24	51.50	47.38	43.71	42.93	40.21	39.98	41.63	39.48
Total Assets	26.04	34.70	84.76	94.10	101.00	105.66	97.42	92.26	96.39	99.45	109.35	112.27	124.83
Total Current Liabilities	16.55	21.39	46.25	44.28	40.37	42.87	34.36	24.14	25.31	24.08	27.20	26.17	31.67
Long Term Debt	2.31	4.51	19.94	17.25	8.51	4.80	2.17	4.46	2.18	0.92	0.45	0.45	0.45
Total Non-Current Liabilities	2.90	5.09	22.04	19.95	10.69	6.33	3.97	6.62	4.63	3.11	1.79	1.00	1.59
Total Liabilities	19.45	26.49	68.29	64.24	51.06	49.20	38.33	30.76	29.94	27.18	28.98	27.17	33.25
Total Shareholders' Equity	6.58	8.21	16.47	29.86	49.93	56.46	59.09	61.50	66.45	72.26	80.37	85.10	91.57
Total Equity	6.58	8.21	16.47	29.86	49.93	56.46	59.09	61.50	66.45	72.26	80.37	85.10	91.57
Total Liabilities & Equity	26.04	34.70	84.76	94.10	101.00	105.66	97.42	92.26	96.39	99.45	109.35	112.27	124.83

Cash Flow

Abridged

Understanding Cash Flow Statement

Denis Chem Lab Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	2.58	2.98	2.27	8.53	7.74	10.41	10.62	8.19	13.15	16.39	17.37	12.25	17.36
Working Capital - Increase/(Decrease)	-2.78	-6.23	11.66	-7.30	-1.33	-5.31	0.08	-1.59	3.36	-0.22	0.97	0.16	-11.21
Net CF from Operating Activities	-0.20	-3.26	13.93	1.23	6.41	5.10	10.70	6.59	16.51	16.16	18.34	12.41	6.15
Capital Expenditures - Net	0.42	1.41	12.67	2.18	8.34	8.52	2.19	1.84	5.49	4.70	6.93	7.63	4.66
Net CF from Investing Activities	-0.40	-1.50	-12.67	-1.56	-16.45	-2.16	-2.20	-1.31	-10.33	-11.62	-15.96	-9.06	-7.82
Dividends Paid - Cash - Total	-	-	-	-	-	-	1.68	-	1.04	2.08	2.78	3.47	2.08
Stock - Issuance/(Retirement) - Net	0.07	-	4.05	2.70	2.13	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-0.59	5.77	-4.30	-6.62	-12.27	-2.11	-9.33	-3.95	-5.40	-1.28	-0.89	-0.23	3.36
Net Cash Flow from Financing Activities	-0.40	6.06	-0.25	5.53	5.66	-2.11	-11.01	-3.95	-6.44	-3.37	-3.66	-3.69	1.28
Free Cash Flow to Equity	-1.21	1.10	-3.05	-7.57	-14.20	-5.54	-0.82	0.81	5.61	10.18	10.52	4.55	4.85
Free Operating CF net dividend	-0.62	-4.67	1.25	-0.95	-1.93	-4.47	6.83	4.76	9.97	9.39	8.63	1.31	-0.60
Free Operating CF	-0.62	-4.67	1.25	-0.95	-1.93	-4.47	8.51	4.76	11.01	11.47	11.41	4.78	1.48

Business Segment Analysis

FY End:

Mar 26

Denis Chem Lab Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Manufacturing & sales of transfusion solutions (100.0%)₹ 4.66 Cr

Revenue / Sales

Manufacturing & sales of transfusion solutions (100.0%)₹ 181.72 Cr

Assets

Manufacturing & sales of transfusion solutions (100.0%)₹ 124.83 Cr

Operating Income

Manufacturing & sales of transfusion solutions (100.0%)₹ 10.81 Cr

Regional Segment Analysis

Denis Chem Lab Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Denis Chem Lab Ltd.

Historical Segment Analysis

Track how Denis Chem Lab Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2025 Mar 31	2026 Mar 31
	2025 Mar 31	2026 Mar 31
Manufacturing & sales of transfusion solutions	8	5

Frequently Asked Questions

What is the revenue of Denis Chem Lab Ltd.?

The latest trailing twelve month revenue of Denis Chem Lab Ltd. is ₹ 182.44 Cr, reflecting a 1-year growth of 4.06% and a 3-year CAGR of 3.61%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Denis Chem Lab Ltd.?

The latest trailing twelve month net profit (PAT) of Denis Chem Lab Ltd. is ₹ 7.98 Cr, with a 3-year earnings CAGR of 2.30%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Denis Chem Lab Ltd.?

The trailing twelve month EBITDA of Denis Chem Lab Ltd. is approximately ₹ 9.91 Cr (based on an operating margin of 5.43%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Denis Chem Lab Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Denis Chem Lab Ltd. is 6.06. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Denis Chem Lab Ltd.?

The debt-to-equity ratio of Denis Chem Lab Ltd. stands at 0.05. The interest coverage ratio is 12.99x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Denis Chem Lab Ltd.?

The estimated book value per share of Denis Chem Lab Ltd. is 65.99 (derived from a P/B ratio of 1.11 and market price of ₹ 73.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Denis Chem Lab Ltd.?

The trailing twelve month operating cash flow of Denis Chem Lab Ltd. is ₹ 6.14 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Denis Chem Lab Ltd. report consolidated or standalone financials?

Denis Chem Lab Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.